Preparation and evaluation of parathyroid hormone incorporated CaP coating via a biomimetic method

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 97 B, Issue 2, 2011, Pages 345-354

  Yu, Xiaohua ^a   Wei, Mei ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

biomimetic coating; calcium phosphate; local delivery; osteoblast; PTH

Indexed keywords

ALKALINE PHOSPHATASE; BIOMIMETIC COATING; BIOMIMETIC METHOD; BONE GROWTH; CLINICAL APPLICATION; CO-PRECIPITATION PROCESS; COATING MORPHOLOGY; CONTROLLED DELIVERY; DISEASE TREATMENT; IN-VITRO; LOCAL DELIVERY; PARATHYROID HORMONES; PARTIAL DISSOLUTION; PTH; SIDE EFFECT; SIMULATED BODY FLUIDS; TITANIUM SURFACES;

BIOMIMETICS; BONE; CALCIUM; CALCIUM PHOSPHATE; CELL CULTURE; CELL PROLIFERATION; DISSOLUTION; PHOSPHATASES; PHOSPHATES; TITANIUM;

COATINGS;

ALKALINE PHOSPHATASE; CALCIUM PHOSPHATE; PARATHYROID HORMONE; TITANIUM;

ARTICLE; BIOMIMETICS; BODY FLUID; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DISSOLUTION; DRUG ACTIVITY; HORMONE RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; MATERIAL COATING; PRECIPITATION; PROTEIN EXPRESSION; SIMULATION;

3T3 CELLS; ALKALINE PHOSPHATASE; ANIMALS; BIOMIMETICS; BODY FLUIDS; CALCIUM PHOSPHATES; CELL ADHESION; CELL PROLIFERATION; COATED MATERIALS, BIOCOMPATIBLE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EXTRACELLULAR MATRIX; HUMANS; MATERIALS TESTING; MICE; PARATHYROID HORMONE; SURFACE PROPERTIES; TITANIUM;

EID: 79953777958     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31820     Document Type: Article

References (59)

1. Kokubo T, Takadama H,. How useful is SBF in predicting in vivo bone bioactivity? Biomaterials 2006; 27: 2907-2915. (Pubitemid 43208916)
2. Oyane A, Kim HM, Furuya T, Kokubo T, Miyazaki T, Nakamura T,. Preparation and assessment of revised simulated body fluids. J Biomed Mater Res A 2003; 65: 188-195. (Pubitemid 37521424)
3. Lu X, Zhao Z, Leng Y,. Biomimetic calcium phosphate coatings on nitric-acid-treated titanium surfaces. Mater Sci Eng C 2007; 27: 700-708. (Pubitemid 46617239)
4. Habibovic P, van der Valk CM, van Blitterswijk CA, De Groot K, Meijer G,. Influence of octacalcium phosphate coating on osteoinductive properties of biomaterials. J Mater Sci Mater Med 2004; 15: 373-380. (Pubitemid 39012147)
5. 3. Bone 1999; 25: 107S-111S. (Pubitemid 29333192)
6. Habibovic P, Barrere F, van Blitterswijk CA, de Groot K, Layrolle P,. Biomimetic hydroxyapatite coating on metal implants. J Am Ceram Soc 2002; 85: 517-522.
7. Leeuwenburgh S, Layrolle P, Barrere F, de Bruijn J, Schoonman J, van Blitterswijk CA, de Groot K, Osteoclastic resorption of biomimetic calcium phosphate coatings in vitro. J Biomed Mater Res 2001; 56: 208-215. (Pubitemid 32520695)
8. Murphy WL, Hsiong S, Richardson TP, Simmons CA, Mooney DJ,. Effects of a bone-like mineral film on phenotype of adult human mesenchymal stem cells in vitro. Biomaterials 2005; 26: 303-310. (Pubitemid 38950714)
9. Murphy WL, Peters MC, Kohn DH, Mooney DJ,. Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials 2000; 21: 2521-2527.
10. Chou YF, Chiou WA, Xu Y, Dunn JC, Wu BM,. The effect of pH on the structural evolution of accelerated biomimetic apatite. Biomaterials 2004; 25: 5323-5331. (Pubitemid 38521170)
11. Kim HM, Himeno T, Kokubo T, Nakamura T,. Process and kinetics of bonelike apatite formation on sintered hydroxyapatite in a simulated body fluid. Biomaterials 2005; 26: 4366-4373. (Pubitemid 40208597)
12. Kokubo T,. Apatite formation on surfaces of ceramics, metals and polymers in body environment. Acta Mater 1998; 46: 2519-2527. (Pubitemid 128395164)
13. Kokubo T, Ito S, Huang ZT, Hayashi T, Sakka S, Kitsugi T, Yamamuro T,. Ca,P-rich layer formed on high-strength bioactive glass-ceramic A-W. J Biomed Mater Res 1990; 24: 331-343. (Pubitemid 20132804)
14. Liu Y, Li JP, Hunziker EB, De Groot K,. Incorporation of growth factors into medical devices via biomimetic coatings. Philos Transact A Math Phys Eng Sci 2006; 364: 233-248. (Pubitemid 43129283)
15. Chou YF, Dunn JC, Wu BM,. In vitro response of MC3T3-E1 pre-osteoblasts within three-dimensional apatite-coated PLGA scaffolds. J Biomed Mater Res B Appl Biomater 2005; 75: 81-90. (Pubitemid 41395747)
16. Kim HM, Miyaji F, Kokubo T, Nakamura T,. Effect of heat treatment on apatite-forming ability of Ti metal induced by alkali treatment. J Mater Sci Mater Med 1997; 8: 341-347. (Pubitemid 27254756)
17. Zhu L, Ye X, Tang G, Zhao N, Gong Y, Zhao Y, Zhao J, Zhang X,. Biomimetic coating of compound titania and hydroxyapatite on titanium. J Biomed Mater Res A 2007; 83: 1165-1175. (Pubitemid 350231779)
18. Liu Y, Hunziker EB, Randall NX, de Groot K, Layrolle P,. Proteins incorporated into biomimetically prepared calcium phosphate coatings modulate their mechanical strength and dissolution rate. Biomaterials 2003; 24: 65-70. (Pubitemid 35300204)
19. Stigter M, Bezemer J, de Groot K, Layrolle P,. Incorporation of different antibiotics into carbonated hydroxyapatite coatings on titanium implants, release and antibiotic efficacy. J Control Release 2004; 99: 127-137. (Pubitemid 39165739)
20. Uchida M, Oyane A, Kim HM, Kokubo T, Ito A,. Biomimetic coating of laminin-apatite composite on titanium metal and its excellent cell-adhesive properties. Adv Mater 2004; 16: 1071-1074.
21. Stigter M, de Groot K, Layrolle P,. Incorporation of tobramycin into biomimetic hydroxyapatite coating on titanium. Biomaterials 2002; 23: 4143-4153. (Pubitemid 34765705)
22. Shen H, Tan J, Saltzman WM,. Surface-mediated gene transfer from nanocomposites of controlled texture. Nat Mater 2004; 3: 569-574.
23. Oliveira AL, Pedro AJ, Arroyo CS, Mano JF, Rodriguez G, Roman JS, Reis RL,. Biomimetic Ca-P coatings incorporating bisphosphonates produced on starch-based degradable biomaterials. J Biomed Mater Res B Appl Biomater 2010; 92: 55-67.
24. Luong LN, McFalls KM, Kohn DH,. Gene delivery via DNA incorporation within a biomimetic apatite coating. Biomaterials 2009; 30: 6996-7004.
25. Liu Y, De Groot K, Hunziker EB,. BMP-2 liberated from biomimetic implant coatings induces and sustains direct ossification in an ectopic rat model. Bone 2005; 36: 745-757. (Pubitemid 40626762)
26. Liu YM, de Groot K, Hunziker EB,. Cell-mediated protein release from calcium-phosphate-coated titanium implants. J Control Release 2005; 101: 346-347.
27. Liu Y, Enggist L, Kuffer AF, Buser D, Hunziker EB,. The influence of BMP-2 and its mode of delivery on the osteoconductivity of implant surfaces during the early phase of osseointegration. Biomaterials 2007; 28: 2677-2686. (Pubitemid 46367217)
28. Choi S, Murphy WL,. Sustained plasmid DNA release from dissolving mineral coatings. Acta Biomater 2010; 6: 3426-3435.
29. Tam CS, Heersche JNM, Murray TM, Parsons JA,. Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: Differential effects of intermittent and continuous administration. Endocrinology 1982; 110: 506-512. (Pubitemid 12162946)
30. Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD,. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 1996; 11: 337-349. (Pubitemid 26076383)
31. Nakajima A, Shimoji N, Shiomi K, Shimizu S, Moriya H, Einhorn TA, Yamazaki M,. Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34). J Bone Miner Res 2002; 17: 2038-2047. (Pubitemid 35239205)
32. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH,. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. New Engl J Med 2001; 344: 1434-1441. (Pubitemid 32402100)
33. Andreassen TT, Ejersted C, Oxlund H,. Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures. J Bone Miner Res 1999; 14: 960-968. (Pubitemid 29262891)
34. Frolik CA, Black EC, Cain RL, Satterwhite JH, Brown-Augsburger PL, Sato M, Hock JM,. Anabolic and catabolic bone effects of human parathyroid hormone (1-34) are predicted by duration of hormone exposure. Bone 2003; 33: 372-379. (Pubitemid 37103254)
35. Jung RE, Cochran DL, Domken O, Seibl R, Jones AA, Buser D, Hammerle CH,. The effect of matrix bound parathyroid hormone on bone regeneration. Clin Oral Implants Res 2007; 18: 319-325.
36. Jilka RL, O'Brien CA, Ali AA, Roberson PK, Weinstein RS, Manolagas SC,. Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts. Bone 2009; 44: 275-286.
37. Seebach C, Skripitz R, Andreassen TT, Aspenberg P,. Intermittent parathyroid hormone (1-34) enhances mechanical strength and density of new bone after distraction osteogenesis in rats. J Orthop Res 2004; 22: 472-478. (Pubitemid 38489721)
38. Tashjian AH, Gagel RF,. Teriparatide [human PTH(1-34)]: 2.5 years of experience on the use and safety of the drug for the treatment of osteoporosis. J Bone Miner Res 2006; 21: 354-365.
39. Hodsman AB, Bauer DC, Dempster DW, Dian L, Hanley DA, Harris ST, Kendler DL, McClung MR, Miller PD, Olszynski WP, Orwoll E, Yuen CK,. Parathyroid hormone and teriparatide for the treatment of osteoporosis: A review of the evidence and suggested guidelines for its use. Endocr Rev 2005; 26: 688-703. (Pubitemid 41127277)
40. Compston JE,. Skeletal actions of intermittent parathyroid hormone: Effects on bone remodelling and structure. Bone 2007; 40: 1447-1452. (Pubitemid 46756408)
41. Ishizuya T, Yokose S, Hori M, Noda T, Suda T, Yoshiki S, Yamaguchi A,. Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells. J Clin Invest 1997; 99: 2961-2970. (Pubitemid 27278673)
42. Isogai Y, Akatsu T, Ishizuya T, Yamaguchi A, Hori M, Takahashi N, Suda T,. Parathyroid hormone regulates osteoblast differentiation positively or negatively depending on the differentiation stages. J Bone Miner Res 1996; 11: 1384-1393. (Pubitemid 26330991)
43. Whitfield J, Morley P, Willick G,. The parathyroid hormone, its fragments and analogues-Potent bone-builders for treating osteoporosis. Expert Opin Invest Drugs 2000; 9: 1293-1315. (Pubitemid 30342616)
44. Grey A,. Emerging pharmacologic therapies for osteoporosis. Expert Opin Emerg Drugs 2007; 12: 493-508. (Pubitemid 47518381)
45. Rizzoli R, Ferrari SL, Pizurki L, Caverzasio J, Bonjour JP,. Actions of parathyroid hormone and parathyroid hormone-related protein. J Endocri Invest 1992; 15: 51-56.
46. Luginbuehl V, Meinel L, Merkle HP, Gander B,. Localized delivery of growth factors for bone repair. Eur J Pharm Biopharm 2004; 58: 197-208. (Pubitemid 39037229)
47. Panyam J, Labhasetwar V,. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003; 55: 329-347. (Pubitemid 36297053)
48. Uhrich KE, Cannizzaro SM, Langer RS, Shakesheff KM,. Polymeric systems for controlled drug release. Chem Rev 1999; 99: 3181-3198. (Pubitemid 129583051)
49. Qu H, Wei M,. The effect of temperature and initial pH on biomimetic apatite coating. J Biomed Mater Res B Appl Biomater 2008; 87: 204-212.
50. Sabokbar A, Millett PJ, Myer B, Rushton N,. A rapid, quantitative assay for measuring alkaline phosphatase activity in osteoblastic cells in vitro. Bone Miner 1994; 27: 57-67.
51. Fang J, Zhu YY, Smiley E, Bonadio J, Rouleau JP, Goldstein SA, McCauley LK, Davidson BL, Roessler BJ,. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc Natl Acad Sci USA 1996; 93: 5753-5758. (Pubitemid 26190752)
52. Arrighi I, Mark S, Alvisi M, von Rechenberg B, Hubbell JA, Schense JC,. Bone healing induced by local delivery of an engineered parathyroid hormone prodrug. Biomaterials 2009; 30: 1763-1771.
53. Wang J, Layrolle P, Stigter M, de Groot K,. Biomimetic and electrolytic calcium phosphate coatings on titanium alloy: Physicochemical characteristics and cell attachment. Biomaterials 2004; 25: 583-592. (Pubitemid 37357273)
54. Yu X, Qu H, Knecht D, Wei M,. Incorporation of bovine serum albumin into biomimetic coatings on titanium with high loading efficacy and its release behavior. J Mater Sci Mater Med 2009; 20: 287-294.
55. Chunxiao W, Jingjing L, Yire X, Min D, Zhaohui W, Gaofu Q, Xiangchun S, Xuejun W, Jie W, Taiming L,. Study on preparation and activity of a novel recombinant human parathyroid hormone(1-34) analog with N-terminal Pro-Pro extension. Regul Pept 2007; 141: 35-43. (Pubitemid 46482694)
56. Liu Y, Layrolle P, de Bruijn J, van Blitterswijk C, de Groot K,. Biomimetic coprecipitation of calcium phosphate and bovine serum albumin on titanium alloy. J Biomed Mater Res 2001; 57: 327-335. (Pubitemid 32885264)
57. Vermeulen M, Giordano M, Trevani AS, Sedlik C, Gamberale R, Fern35881 ndez-Calotti P, et al. Acidosis improves uptake of antigens and MHC class I-restricted presentation by dendritic cells. J Immunol 2004; 172: 3196-3204. (Pubitemid 38263711)
58. Bagambisa FB, Joos U, Schilli W,. Mechanisms and structure of the bond between bone and hydroxyapatite ceramics. J Biomed Mater Res 1993; 27: 1047-1055. (Pubitemid 23206720)
59. Wang YH, Liu Y, Buhl K, Rowe DW,. Comparison of the action of transient and continuous PTH on primary osteoblast cultures expressing differentiation stage-specific GFP. J Bone Miner Res 2005; 20: 5-14. (Pubitemid 41716213)